EUVIMEDEUVIMED entdecken
Open Access

A novel tumor-associated macrophage risk signature predicts prognosis and immunotherapy response in lung adenocarcinoma

Yingchuan Zhu, Yue Song, Wenhao Jiang, Jingfei Zhang, Lan Yin, Xinyu Lin, Yilu Lu, Dachang Tao, Yongxin Ma

American Journal of Cancer Research · 2025 · 15 (3) · 876-893

DOI: 10.62347/squf6988 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Cancer Research, 2025. Verfasst von Yingchuan Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University Chengdu 610041, Sichuan, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

PD-L1Tumor-associated macrophages (TAMs)lung adenocarcinomaprognosis-related signaturessingle-cell RNA-sequencing (scRNA-seq)

Autor:innen und Institutionen

  • Department of Medical Genetics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University Chengdu 610041, Sichuan, China.

Zitieren

APA

Zhu, Y., Song, Y., Jiang, W., Zhang, J., Yin, L., Lin, X., Lu, Y., Tao, D., & Ma, Y. (2025). A novel tumor-associated macrophage risk signature predicts prognosis and immunotherapy response in lung adenocarcinoma. American Journal of Cancer Research, 15(3), 876-893. https://doi.org/10.62347/squf6988

Vancouver

Zhu Y, Song Y, Jiang W, Zhang J, Yin L, Lin X, et al. A novel tumor-associated macrophage risk signature predicts prognosis and immunotherapy response in lung adenocarcinoma. American Journal of Cancer Research. 2025;15(3):876-893. doi:10.62347/squf6988

BibTeX
@article{Zhu2025,
  author = {Zhu, Yingchuan and Song, Yue and Jiang, Wenhao and Zhang, Jingfei and Yin, Lan and Lin, Xinyu and Lu, Yilu and Tao, Dachang and Ma, Yongxin},
  title = {A novel tumor-associated macrophage risk signature predicts prognosis and immunotherapy response in lung adenocarcinoma},
  journal = {American Journal of Cancer Research},
  year = {2025},
  volume = {15},
  number = {3},
  pages = {876--893},
  doi = {10.62347/squf6988}
}
Kostenlos starten →